Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 518

1.

Detection and Clinical Patterns of Nephron Hypertrophy and Nephrosclerosis Among Apparently Healthy Adults.

Denic A, Alexander MP, Kaushik V, Lerman LO, Lieske JC, Stegall MD, Larson JJ, Kremers WK, Vrtiska TJ, Chakkera HA, Poggio ED, Rule AD.

Am J Kidney Dis. 2016 Jul;68(1):58-67. doi: 10.1053/j.ajkd.2015.12.029. Epub 2016 Feb 6.

PMID:
26857648
2.

Transforming Living Kidney Donation with a Comprehensive Strategy.

Allen MB, Reese PP.

PLoS Med. 2016 Feb 2;13(2):e1001948. doi: 10.1371/journal.pmed.1001948. eCollection 2016 Feb. Review.

3.

Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors.

Moody WE, Ferro CJ, Edwards NC, Chue CD, Lin EL, Taylor RJ, Cockwell P, Steeds RP, Townend JN; CRIB-Donor Study Investigators.

Hypertension. 2016 Feb;67(2):368-77. doi: 10.1161/HYPERTENSIONAHA.115.06608.

4.

LIVING DONOR NEPHRECTOMY: OPEN vs LAPARASCOPY. Renal Function and Complications.

Maroun M, Anthony KC, Samir R, Fouad A, Fouad N, David A, Samir M, Chebl M.

J Med Liban. 2015 Jul-Sep;63(3):144-9.

PMID:
26591194
5.

Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.

Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX; Chronic Kidney Disease Prognosis Consortium.

N Engl J Med. 2016 Feb 4;374(5):411-21. doi: 10.1056/NEJMoa1510491. Epub 2015 Nov 6.

PMID:
26544982
6.

A Successful Renal Transplantation Case After Stem Cell Transplantation.

Yilmaz VT, Koksoy S, Ulger BV, Salim O, Akbas H, Aliosmanoglu İ, Erbis H, Kocak H, Suleymanlar G.

Transplant Proc. 2015 Sep;47(7):2233-5. doi: 10.1016/j.transproceed.2015.05.012.

PMID:
26361686
7.

Candida-associated pseudo-aneurysm of the transplant renal artery presenting as malignant hypertension and managed successfully without nephrectomy.

Madhav D, Kumar P, Mohan C; Vijay, Mahesh U; Anusha; Suneetha; Suryaprakash.

Saudi J Kidney Dis Transpl. 2015 Sep;26(5):1000-5. doi: 10.4103/1319-2442.164591. No abstract available.

8.

A 4-year follow-up of living unrelated donors of kidney allograft in Iran.

Nobakht Haghighi A, Malakoutian T, Radfar M, Abdi E, Kamgar M, Broumand B, Fazel I.

Iran J Kidney Dis. 2015 Jul;9(4):273-8.

9.

Long-term health-related quality of life of living kidney donors: a single-center experience.

Benzing C, Hau HM, Kurtz G, Schmelzle M, Tautenhahn HM, Morgül MH, Wiltberger G, Broschewitz J, Atanasov G, Bachmann A, Bartels M.

Qual Life Res. 2015 Dec;24(12):2833-42. doi: 10.1007/s11136-015-1027-2. Epub 2015 Jul 7.

PMID:
26149394
10.

Risk of pre-eclampsia after kidney donation: Primum non nocere.

Jha V.

Natl Med J India. 2014 Nov-Dec;27(6):324-5. No abstract available.

PMID:
26133329
11.

Donor Contraindications to Living Kidney Donation: A Single-Center Experience.

Mağden K, Ucar FB, Velioğlu A, Arıkan H, Yeğen ŞC, Tuğlular S, Özener IÇ.

Transplant Proc. 2015 Jun;47(5):1299-301. doi: 10.1016/j.transproceed.2015.04.050.

PMID:
26093703
12.

Marginal Donors in Renal Transplantation.

Bozkurt B, Kılıç M.

Transplant Proc. 2015 Jun;47(5):1273-81. doi: 10.1016/j.transproceed.2015.04.006. Review.

PMID:
26093697
13.

Living kidney donation: outcomes, ethics, and uncertainty.

Reese PP, Boudville N, Garg AX.

Lancet. 2015 May 16;385(9981):2003-13. doi: 10.1016/S0140-6736(14)62484-3. Review.

PMID:
26090646
14.

Specificities of transplantation of kidneys procured from donors with situs inversus totalis--a case report and review of the literature.

Petrović M, Rabrenović V, Stamenković D, Vavić N, Kovačević Z, Ignjatović L, Jovanović D, Antić S, Milović N, Tomić A, Bančević V.

Vojnosanit Pregl. 2015 Jan;72(1):63-7. Review.

PMID:
26043594
15.

Living-donor and Deceased-donor Renal Transplantation: Differences in Early Outcome--A Single-center Experience.

Guimarães J, Araújo AM, Santos F, Nunes CS, Casal M.

Transplant Proc. 2015 May;47(4):958-62. doi: 10.1016/j.transproceed.2015.03.008.

PMID:
26036494
16.

A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.

Fujimoto T, Nakada Y, Yamamoto I, Kobayashi A, Tanno Y, Yamada H, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.

Nephrology (Carlton). 2015 Jul;20 Suppl 2:81-5. doi: 10.1111/nep.12453.

PMID:
26031594
17.

Kidney Donation: What Might It Mean for Women Wishing to Become Pregnant.

Hladunewich MA, Kim SJ.

Am J Kidney Dis. 2015 Sep;66(3):386-8. doi: 10.1053/j.ajkd.2015.04.002. Epub 2015 May 16. No abstract available.

PMID:
25987264
18.

Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know.

Wiseman AC.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):923-5. doi: 10.2215/CJN.03800415. Epub 2015 May 15. No abstract available.

19.

Outcomes of living kidney donors with monoclonal gammopathy of undetermined significance.

Cheungpasitporn W, Thongprayoon C, Erickson SB.

Ren Fail. 2015 Jul;37(6):1070-1. doi: 10.3109/0886022X.2015.1044402. Epub 2015 May 12. No abstract available.

PMID:
25962495
20.

Long-term medical risks to the living kidney donor.

Lam NN, Lentine KL, Levey AS, Kasiske BL, Garg AX.

Nat Rev Nephrol. 2015 Jul;11(7):411-9. doi: 10.1038/nrneph.2015.58. Epub 2015 May 5. Review.

PMID:
25941060
Items per page

Supplemental Content

Loading ...
Write to the Help Desk